Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 1
2007 2
2008 1
2009 1
2010 4
2011 6
2012 2
2013 6
2014 5
2015 3
2016 4
2017 4
2018 6
2019 3
2020 7
2021 9
2022 9
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Exploring factors associated with Trichuris trichiura infection in school children in a high-transmission setting in Kenya.
Kepha S, Mazigo HD, Odiere MR, Mcharo C, Safari T, Gichuki PM, Omondi W, Wakesho F, Krolewiecki A, Pullan RL, Mwandawiro CS, Oswald WE, Halliday KE. Kepha S, et al. Among authors: krolewiecki a. IJID Reg. 2024 Mar 20;11:100352. doi: 10.1016/j.ijregi.2024.03.007. eCollection 2024 Jun. IJID Reg. 2024. PMID: 38634069 Free PMC article.
Clinical Presentation of American Tegumentary Leishmaniasis in a Leishmania (Viannia) braziliensis Endemic Hotspot: A 35-Year History.
Almazán MC, Cajal SP, Díaz-Fernández M, Juárez M, Quipildor M, Portal G, Tejerina V, Vargas C, Copa GN, Gil JF, Cimino RO, Krolewiecki AJ. Almazán MC, et al. Among authors: krolewiecki aj. Am J Trop Med Hyg. 2023 Aug 21;109(4):804-810. doi: 10.4269/ajtmh.23-0234. Print 2023 Oct 4. Am J Trop Med Hyg. 2023. PMID: 37604471
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol.
Krolewiecki A, Enbiale W, Gandasegui J, van Lieshout L, Kepha S, Messa Junior A, Bengtson M, Gelaye W, Escola V, Martinez-Valladares M, Cambra-Pellejà M, Algorta J, Martí-Soler H, Fleitas P, Ballester MR, Doyle SR, Williams NA, Legarda A, Mandomando I, Mwandawiro C, Muñoz J. Krolewiecki A, et al. Gates Open Res. 2022 May 5;6:62. doi: 10.12688/gatesopenres.13615.1. eCollection 2022. Gates Open Res. 2022. PMID: 36540062 Free PMC article.
Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers.
Algorta J, Krolewiecki A, Pinto F, Gold S, Muñoz J. Algorta J, et al. Among authors: krolewiecki a. Front Pharmacol. 2022 Jul 14;13:914886. doi: 10.3389/fphar.2022.914886. eCollection 2022. Front Pharmacol. 2022. PMID: 35910353 Free PMC article.
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.
Gandasegui J, Onwuchekwa C, Krolewiecki AJ, Doyle SR, Pullan RL, Enbiale W, Kepha S, Hatherell HA, van Lieshout L, Cambra-Pellejà M, Escola V, Muñoz J. Gandasegui J, et al. Among authors: krolewiecki aj. Lancet Infect Dis. 2022 Nov;22(11):e341-e347. doi: 10.1016/S1473-3099(22)00369-3. Epub 2022 Jul 15. Lancet Infect Dis. 2022. PMID: 35850127 Review.
Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients.
Mayer MA, Krolewiecki A, Ferrero A, Bocchio M, Barbero J, Miguel M, Paladini A, Delgado C, Ojeda JR, Elorza C, Bertone A, Fleitas PE, Vera G, Kohan MR. Mayer MA, et al. Among authors: krolewiecki a. Front Public Health. 2022 Feb 22;10:813378. doi: 10.3389/fpubh.2022.813378. eCollection 2022. Front Public Health. 2022. PMID: 35273939 Free PMC article.
77 results